Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 3:13:662786.
doi: 10.3389/fnagi.2021.662786. eCollection 2021.

COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications

Affiliations

COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications

Rajkumar Singh Kalra et al. Front Aging Neurosci. .

Abstract

The spectrum of health complications instigated by coronavirus disease 2019 (COVID-19, caused by the novel severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2) pandemic has been diverse and complex. Besides the evident pulmonary and cardiovascular threats, accumulating clinical data points to several neurological complications, which are more common in elderly COVID-19 patients. Recent pieces of evidence have marked events of neuro infection and neuroinvasion, producing several neurological complications in COVID-19 patients; however, a systematic understanding of neuro-pathophysiology and manifested neurological complications, more specifically in elderly COVID-19 patients is largely elusive. Since the elderly population gradually develops neurological disorders with aging, COVID-19 inevitably poses a higher risk of neurological manifestations to the aged patients. In this report, we reviewed SARS-CoV-2 infection and its role in neurological manifestations with an emphasis on the elderly population. We reviewed neuropathological events including neuroinfection, neuroinvasion, and their underlying mechanisms affecting neuromuscular, central- and peripheral- nervous systems. We further assessed the imminent neurological challenges in the COVID-19 exposed population, post-SARS-CoV-2-infection. Given the present state of clinical preparedness, the emerging role of AI and machine learning was also discussed concerning COVID-19 diagnostics and its management. Taken together, the present review summarizes neurological outcomes of SARS-CoV-2 infection and associated complications, specifically in elderly patients, and underlines the need for their clinical management in advance.

Keywords: COVID-19; SARS-CoV-2; aging; neurodegenerative disease; neuroinfection; neuroinvasion; neuropathology; pandemic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Coronavirus disease 2019 (COVID-19) neuro-pathophysiology: COVID-19 clinical manifestations associated with diverse neuronal systems/organs including the peripheral nerve, parenchymal, cerebrovascular, meningeal, spinal cord, neuromuscular, and cranial nerve in SARS-CoV-2-infected patients.
Figure 2
Figure 2
Schematic diagram showing potential modes of SARS-CoV-2 neuroinfection via neuronal/nervous, epithelial-humoral, infected immune/lymphatic, and lymphatic-cerebrospinal fluid routes.

References

    1. Abdi S., Ghorbani A., Fatehi F. (2020). The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms. J. Neurol. Sci. 416:117001. 10.1016/j.jns.2020.117001 - DOI - PMC - PubMed
    1. Achar A., Ghosh C. (2020). COVID-19-associated neurological disorders: the potential route of cns invasion and blood-brain relevance. Cells 9:2360. 10.3390/cells9112360 - DOI - PMC - PubMed
    1. Agrawal L., Poullikkas T., Eisenhower S., Monsanto C., Bakku R. K., Chen M. H. (2021). Viroinformatics-based analysis of SARS-CoV-2 core proteins for potential therapeutic targets. Antibodies 10:3. 10.3390/antib10010003 - DOI - PMC - PubMed
    1. Alghatrif M., Cingolani O., Lakatta E. G. (2020). The dilemma of coronavirus disease 2019, aging and cardiovascular disease: insights from cardiovascular aging science. JAMA Cardiol. 5, 747–748. 10.1001/jamacardio.2020.1329 - DOI - PMC - PubMed
    1. Allan S. M., Rothwell N. J. (2001). Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2, 734–744. 10.1038/35094583 - DOI - PubMed